Fresenius Kabi Oncology Ltd Stock
Equities
INE575G01010
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- INR | - |
2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-06-30 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 08-08-10 | |
Director/Board Member | - | 07-07-20 | |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
1st Jan change | Capi. | |
---|---|---|
+18.34% | 125B | |
+15.06% | 108B | |
-6.39% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.07% | 16.34B | |
+1.05% | 13.56B | |
+25.87% | 11.59B |
- Stock Market
- Equities
- Stock